Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Feb 21;38(8):574-576.
doi: 10.1093/eurheartj/ehw166.

Improving the yield of genetic testing in familial hypercholesterolaemia

Ezim Ajufo, Marina Cuchel
Editorial

Improving the yield of genetic testing in familial hypercholesterolaemia

Ezim Ajufo et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Variables assessed to determine the probability of genetically confirmed familial hypercholesterolaemia (FH) under current criteria vs. under the newly proposed model. Variables listed under ‘current criteria’ are a generalization of the Dutch Lipid Clinic Network (DLCN) and Simon Broome FH Register (SB) criteria. Variables listed are dichotomous unless otherwise indicated. CVD, cardiovascular disease, TC, total cholesterol; TG, triglyceride. ‡Coded under four discrete categories: no CVD event, non-premature CVD event, CVD event at unknown age, premature CVD event.
See this image and copyright information in PMC

Comment on

References

    1. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AFH, Stroes E, Taskinen M-R, Tybjærg-Hansen A. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J 2013;34:3478–3490. - PMC - PubMed
    1. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 1991;303:893–896. - PMC - PubMed
    1. Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DCG, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJP, Sijbrands EJG. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008;337:a2423. - PMC - PubMed
    1. Umans-Eckenhausen MAW, Defesche JC, Sijbrands EJG, Scheerder RLJM, Kastelein JJP. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 2001;357:165–168. - PubMed
    1. Chen CX, Hay JW. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States. Int J Cardiol 2015;181:417–424. - PubMed